Proton pump inhibitors and severe hypomagnesaemia

Current Opinion in Gastroenterology

Volumn 27, Issue 2, 2011, Pages 180-185

  Cundy, Tim ^a   MacKay, Jonathan ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

hypocalcaemia; hypomagnesaemia; intestinal magnesium absorption; proton pump inhibitors

Indexed keywords

BICARBONATE; CALCIUM; CITRIC ACID; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; MAGNESIUM; OMEPRAZOLE; PANTOPRAZOLE; PARATHYROID HORMONE; PHOSPHATE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ATAXIA; CALCIUM BLOOD LEVEL; DELIRIUM; DIARRHEA; DISEASE SEVERITY; DRUG MEGADOSE; EMERGENCY TREATMENT; FATIGUE; FOOD DEPRIVATION; HOMEOSTASIS; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; INTESTINE ABSORPTION; MAGNESIUM BLOOD LEVEL; MAGNESIUM METABOLISM; PARESTHESIA; REVIEW; SEIZURE; TETANY; UNITED KINGDOM; UNSTEADINESS;

HOMEOSTASIS; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; PROTON PUMP INHIBITORS;

EID: 79951678835     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32833ff5d6     Document Type: Review

References (23)

1. Forgacs I, Loganayagan A. Overprescribing proton pump inhibitors. BMJ 2008; 336:2-3.
2. Hollingworth S, Duncan EL, Martin JH. Marked increase in proton pump inhibitors use in Australia. Pharmacoepidemiol Drug Saf 2010. doi: 10.1002/pds.1969. [Epub ahead of print]
3. Quamme GA. Recent developments in intestinal magnesium absorption. Curr Opin Gastroenterol 2008; 24:230-235. (Pubitemid 351322792)
4. Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Annu Rev Physiol 2006; 68:403-429.
5. Fine KD, Santa Ana CA, Porter JL, Fordtran JS. Intestinal absorption of magnesium from food and supplements. J Clin Invest 1991; 88:396-402.
6. Dimke H, Hoenderop JG, Bindels RJ. Hereditary tubular transport disorders: implications for renal handling of Ca2p and Mg2p. Clin Sci (Lond) 2010; 118:1-18.
7. Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Eng J Med 2006; 355:1834-1836.
8. Metz DC, Stosek MB, Ruszniewski P, et al. Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion. Am J Gastroenterol 2007; 102:2648-2654. (Pubitemid 350179329)
9. Shabajee N, Lamb EJ, Sturgess I, Sumathipala RW. Omeprazole and refractory hypomagnesaemia. BMJ 2008; 337:173-175.
10. Cundy T, Dissanayake A. Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol (Oxf) 2008; 69:338-341. (Pubitemid 352009025)
11. François M, Lévy-Bohbot N, Caron J, Durlach V. Chronic use of proton pump inhibitors associated with giardiasis: a rare cause of hypomagnesemic hypoparathyroidism? Ann Endocrinol (Paris) 2008; 69:446-448.
12. Broeren MA, Geerdink EA, Vader HL, van den Wall Bake AW. Hypomagnesemia induced by several proton-pump inhibitors. Ann Intern Med 2009; 151:755-756.
13. Dornebal J, Bijlsma R, Brouer RML. An unrecognized potential side effect of proton pump inhibitors: hypomagnesaemia. Ned Tidjschr Geenesk 2009; 153:A711.
14. Kuipers MT, Thang HD, Arntzenius AB. Hypomagnesaemia due to use of proton pump inhibitors -a review. Neth J Med 2009; 67:169-172.
15. Hoorn EJ, van der Hoek J, de Man RA, et al. A case series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis 2010; 56:112-116.
16. Regolisti G, Cabassi A, Parenti E, et al. Severe hypomagnesemia during longterm treatment with a proton pump inhibitor. Am J Kidney Dis 2010; 56:168-174.
17. Mackay JD, Bladon PT. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series. QJM 2010; 103:387-395.
18. Jeppesen PB, Staun M, Tjellesen L, Mortensen PB. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut 1998; 43:763-769. (Pubitemid 28539654)
19. Serfaty-Lacrosniere C, Wood RJ, Voytko D, et al. Hypochlorhydria from shortterm omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. J Am Coll Nutr 1995; 14:364-368.
20. Li M, Jiang J, Yue L. Functional characterization of homo-and heteromeric channel kinases TRPM6 and TRPM7. J Gen Physiol 2006; 127:525-537.
21. Evenpoel P. Alteration in digestion and absorption of nutrients during profound acid suppression. Best Pract Res Clin Gastroenterol 2001; 15:539-551.
22. Mullin JM, Valenzano MC, Whitby M, et al. Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase. Aliment Pharmacol Ther 2008; 28:1317-1325.
23. Wilcox GM, Mattia AR. Microscopic colitis associated with omeprazole and esomeprazole exposure. J Clin Gastroenterol 2009; 43:551-553.